Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed Insulin With Acarbose vs Metformin in Type 2 Diabetes (CGM and 1,5-AG)
ChiCTR-IPR-17011324Phase 4Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
- Start
- Jun 2017
- Modality
- Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Premixed insulin + metformin with Premixed insulin + acarbose (2 arms). Primary endpoint: Amplitude of Plasma Glucose Excursions. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
metforminacarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17011324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011324.